Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer
NCT00538395 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2011-12-13
Summary
Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer
Conditions
Interventions
- DRUG
-
Adriamycin, Taxol and Cytoxan
Chemotherapy
Sponsors & Collaborators
-
King Faisal Specialist Hospital & Research Center
lead OTHER
Principal Investigators
-
Adnan Ezzat, MD · KFSH&RC, Riyadh, Saudi Arabia
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2012-09-30
- Completion
- 2013-09-30
More Related Trials
-
Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients
NCT00206518 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00003679 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
NCT00136539 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer
NCT00001239 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
NCT00295893 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
NCT00352378 ·Status: COMPLETED ·Phase: PHASE3
-
Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer
NCT05633914 ·Status: RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
NCT00004092 ·Status: COMPLETED ·Phase: PHASE2
-
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283 ·Status: RECRUITING ·Phase: PHASE1
-
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
NCT00003035 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer
NCT04809844 ·Status: UNKNOWN
-
Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.
NCT00314977 ·Status: COMPLETED ·Phase: PHASE3
-
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
NCT03959891 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer
NCT03556358 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer
NCT00107094 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
NCT00003953 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer
NCT01969032 ·Status: COMPLETED ·Phase: PHASE2
-
CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
NCT04059003 ·Status: UNKNOWN
-
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer
NCT00717951 ·Status: UNKNOWN ·Phase: PHASE2
-
Adj TC + Herceptin Early Stage Breast Cancer
NCT00493649 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
NCT05728268 ·Status: RECRUITING ·Phase: PHASE2
-
Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
NCT00212095 ·Status: COMPLETED ·Phase: PHASE2
-
AKT Inhibitor in Oestrogen Positive Breast Cancer
NCT02077569 ·Status: COMPLETED ·Phase: PHASE2
-
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
NCT03373708 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
German Preoperative Adriamycin Docetaxel Study
NCT00543829 ·Status: COMPLETED ·Phase: PHASE2